Aug. 13 at 2:29 PM
$ELTP $BAC $SPCX $PFE $JNJ
Look at Large Block Purchases, what's up????
Elite Pharmaceuticals has been attracting significant attention in the market recently, not only for its solid fundamentals but also due to notable large block transactions involving major institutional players. The stock, currently valued with a market cap around
$387.9 million and a P/E ratio near 23, has shown promising potential with a 52-week trading range between
$0.33 and
$0.74.
What stands out most is the activity from BAC and major pharmaceutical companies like PFE and JNJ. Bank of America, a key financial institution with deep insights into the pharma sector, has reinstated coverage on several pharmaceutical and biotech stocks, including ELTP. This move signals renewed confidence and interest in the sector's growth prospects.Conference call should be very interesting. .
Below is the picture of Big Pharma Looking to Buy Elite. Is that Roaring Kitty on the left?????????
